AAAAAA
Results: 1-25/52
Authors:
BAX RP
ANDERSON R
CREW J
FLETCHER P
JOHNSON T
KAPLAN E
KNAUS B
KRISTINSSON K
MALEK M
STRANDBERG L
Citation: Rp. Bax et al., ANTIBIOTIC-RESISTANCE - WHAT CAN WE DO, Nature medicine, 4(5), 1998, pp. 545-546
Authors:
MALEK M
Citation: M. Malek, PROMOTING COST-EFFECTIVE PRESCRIBING IN THE UK NATIONAL-HEALTH-SERVICE - BLOOR,K, FREEMANTLE,N, Health economics, 7(1), 1998, pp. 89-90
Authors:
KUJATH S
DHAR A
HANSEN D
MALEK M
PHRUTTITUM S
HELLING T
VANWAY C
Citation: S. Kujath et al., PROTECTIVE EFFECT OF GLUTAMINE UPON LIVER ADENOSINE NUCLEOTIDES DURING HEMORRHAGIC-SHOCK, The FASEB journal, 12(4), 1998, pp. 3222-3222
Authors:
PRACH AT
MALEK M
TAVAKOLI M
HOPWOOD D
SENIOR BW
MURRAY FE
Citation: At. Prach et al., H-2-ANTAGONIST MAINTENANCE THERAPY VERSUS HELICOBACTER-PYLORI ERADICATION IN PATIENTS WITH CHRONIC DUODENAL-ULCER DISEASE - A PROSPECTIVE-STUDY, Alimentary pharmacology & therapeutics, 12(9), 1998, pp. 873-880
Authors:
PANDYA M
MALEK M
Citation: M. Pandya et M. Malek, MINIMUM ACHIEVABLE UTILIZATION FOR FAULT-TOLERANT PROCESSING OF PERIODIC TASKS, I.E.E.E. transactions on computers, 47(10), 1998, pp. 1102-1112
Authors:
MUGFORD M
HOWARD S
ONEILL C
DUNN A
ZELISKO M
NORMAND C
MALEK M
HEY E
HALLIDAY H
TARNOWMORDI W
Citation: M. Mugford et al., LIMITED COMPARABILITY OF CLASSIFICATIONS OF LEVELS OF NEONATAL CARE IN UK UNITS, Archives of Disease in Childhood, 78(3), 1998, pp. 179-184
Authors:
MCINTYRE AM
MACGREGOR S
MALEK M
DUNBAR JA
HAMLEY JG
CROMARTY JA
Citation: Am. Mcintyre et al., NEW PATIENTS PRESENTING TO THEIR GP WITH DYSPEPSIA - DOES HELICOBACTER-PYLORI ERADICATION MINIMIZE THE COST OF MANAGING THESE PATIENTS, International journal of clinical practice, 51(5), 1997, pp. 276-281
Authors:
POLZE A
MALEK M
Citation: A. Polze et M. Malek, NETWORK COMPUTING WITH SONIC, Journal of systems architecture, 44(3-4), 1997, pp. 169-187
Authors:
TARNOWMORDI W
TUCKER J
MCCABE C
PARRY G
MALEK M
HEY E
NORMAND C
MUGFORD M
HALLIDAY H
Citation: W. Tarnowmordi et al., ISSUES IN COST FUNCTION SPECIFICATION FOR NEONATAL CARE - AN INTERDISCIPLINARY PERSPECTIVE, Journal of public health medicine, 19(4), 1997, pp. 479-480
Authors:
MALEK M
Citation: M. Malek, CRIMEA - DYNAMICS, CHALLENGES, AND PROSPE CTS - DROHOBYCKY,M, Osteuropa, 47(7), 1997, pp. 729-730
Authors:
MALEK M
Citation: M. Malek, RUSSIAN SECURITY INTERESTS UBER ALLES, Osteuropa, 47(12), 1997, pp. 1250-1258
Authors:
PRACH AT
MALEK M
HOPWOOD D
SENIOR BW
MURRAY FE
Citation: At. Prach et al., RANITIDINE MAINTENANCE THERAPY VERSUS HELICOBACTER-PYLORI ERADICATIONTHERAPY IN PATIENTS WITH CHRONIC DUODENAL-ULCER DISEASE - SYMPTOM ANDQUALITY-OF-LIFE ANALYSIS, Gut, 41, 1997, pp. 89-89
Authors:
PRACH AT
MALEK M
HOPWOOD D
SENIOR BW
MURRAY FE
Citation: At. Prach et al., HELICOBACTER-PYLORI ERADICATION THERAPY COMPARED WITH RANITIDINE MAINTENANCE THERAPY IN PATIENTS WITH CHRONIC DUODENAL-ULCER DISEASE - A PROSPECTIVE PHARMACOECONOMIC EVALUATION, Gut, 40, 1997, pp. 19-19
Authors:
PRACH AT
MALEK M
HOPWOOD D
SENIOR BW
MURRAY FE
Citation: At. Prach et al., HELICOBACTER-PYLORI ERADICATION THERAPY COMPARED WITH RANITIDINE MAINTENANCE THERAPY IN PATIENTS WITH CHRONIC DUODENAL-ULCER DISEASE - A PROSPECTIVE PHARMACOECONOMIC EVALUATION, Gastroenterology, 112(4), 1997, pp. 261-261
Authors:
NICHOLSON KG
VANDAMME P
MONTO AS
JEFFERSON TO
KUNZE M
LEVY E
SZUCS TD
ENGELS R
FEDSON DS
DUBOIS G
WATSON J
FLEMING D
MALEK M
Citation: Kg. Nicholson et al., THE RATIONALE FOR ECONOMIC-EVALUATION OF INFLUENZA - DISCUSSION - SECTION-1, PharmacoEconomics, 9, 1996, pp. 23-25
Authors:
KUNZE M
JEFFERSON TO
SULLIVAN KM
FEDSON DS
HANNOUN C
WATSON J
MONTO AS
SZUCS TD
MALEK M
SNACKEN R
VANDAMME P
FLEMING DM
NICHOLSON K
BONNANI P
Citation: M. Kunze et al., ECONOMIC-IMPACT OF INFLUENZA - DISCUSSION, PharmacoEconomics, 9, 1996, pp. 50-53
Authors:
MALEK M
Citation: M. Malek, ECONOMIC-EVALUATION OF INFLUENZA VACCINATION AND ECONOMIC MODELING, PharmacoEconomics, 9, 1996, pp. 73-74
Authors:
MALEK M
Citation: M. Malek, CURRENT PRINCIPLES AND APPLICATION OF PHARMACOECONOMICS, PharmacoEconomics, 9, 1996, pp. 1-8
Authors:
CRAIG AM
DAVEY P
MALEK M
MURRAY F
Citation: Am. Craig et al., DECISION-ANALYSIS OF HELICOBACTER-PYLORI ERADICATION THERAPY USING OMEPRAZOLE WITH EITHER CLARITHROMYCIN OR AMOXICILLIN, PharmacoEconomics, 10(1), 1996, pp. 79-92
Authors:
MALEK M
Citation: M. Malek, IMPROVING CLINICAL-PRACTICE - TOTAL QUALITY MANAGEMENT AND THE PHYSICIANS - BLUMENTHAL,D, SHECK,AC, Health economics, 5(6), 1996, pp. 579-580
Authors:
DAVEY PG
SOUTH R
MALEK M
Citation: Pg. Davey et al., IMPACT OF GLYCOPEPTIDE THERAPY AFTER HOSPITAL DISCHARGE ON INPATIENT COSTS - A COMPARISON OF TEICOPLANIN AND VANCOMYCIN, Journal of antimicrobial chemotherapy, 37(3), 1996, pp. 623-633
Authors:
WAKERLY L
CRAIG AM
MALEK M
HOFFMEYER U
LLOYD A
VALETTE F
PHILLIPS R
ZABIHOLLAH M
Citation: L. Wakerly et al., FLUCONAZOLE VERSUS ORAL POLYENES IN THE PROPHYLAXIS OF IMMUNOCOMPROMISED PATIENTS - A COST-MINIMIZATION ANALYSIS, The Journal of hospital infection, 33(1), 1996, pp. 35-48
Authors:
MALEK M
Citation: M. Malek, THE WAR IN CHECHNYA, Osteuropa, 46(6), 1996, pp. 610-616
Authors:
GODDARD JA
MALEK M
TAVAKOLI M
Citation: Ja. Goddard et al., AN ECONOMIC-MODEL OF THE MARKET FOR HOSPITAL TREATMENT FOR NON-URGENTCONDITIONS, Health economics, 4(1), 1995, pp. 41-55
Authors:
KHALFALLAH S
MEZLINI A
MALEK M
TOUATI S
RAIS H
BOUSSEN DH
LADGHAM A
BENAYED F
Citation: S. Khalfallah et al., NEOADJUVANT CHEMOTHERAPY (CT) IN LOCOREGIONALLY - ADVANCED NASOPHARYNGEAL CARCINOMA (NPC) - RESULTS OF A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS, European journal of cancer, 31A, 1995, pp. 409-409